T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2002

Conditions
Multiple Myeloma
Interventions
PROCEDURE

Infusion of Activated & Expanded Autologous T Cells

Trial Locations (6)

21231

Johns Hopkins Medical Institute, Baltimore

63110

Washington University, St Louis

90048

Cedars Sinai Medical Center, Los Angeles

92093

University of California, San Diego, San Diego

94143

University of California, San Francisco, San Francisco

07601

Hackensack University, Hackensack

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Xcyte Therapies

INDUSTRY

NCT00048464 - T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant | Biotech Hunter | Biotech Hunter